We are proud to present our 8th Annual conference on
Adaptive Designs in Clinical Trials taking place on 18th - 19th April in London
In recent years, the use of adaptive design methods has become very popular due to its flexibility for identifying clinical benefits of the testing drug. Adaptive designs offer the potential to reduce timelines and patient exposure while maximising the probability for successful outcomes. However, along with these benefits come challenges: additional complexity, needs for advanced statistical models and increased operational demands.
The 8th annual
Adaptive Clinical Trials conference is designed to highlight an array of topics, including adaptive designs within the context of a development programme, Bayesian analysis in adaptive design, biomarker-driven trials, regulatory issues associated with adaptive design, and more.
A series of practical case studies, interactive roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to:
- Explore the use of adaptive design methods in clinical trials
- Adapt clinical development for immunotherapies in oncology
- Evaluate adaptive designs and Bayesian statistic
- Improve covariant adaptive designs
- Seamless Phase I/II Dose Finding Designs with Efficacy and Safety Endpoints
Benefits of Attending
- Discuss the European regulatory framework and approaches to novel designs
- Evaluate the role of biomarker adaptive designs in oncology
- Examine the role of an independent data safety monitoring board
- Learn adaptive design in Bayesian statistic
- Explore the impact of adaptive changes in clinical trials
- Study the development of new drugs in orphan diseases
- Optimise dose finding design on oncology
Plus an Interactive Half-Day Post-Conference Workshop | Wednesday 20th April 2016
Design, Analysis and Simulation of Adaptive Clinical Trials Using ADDPLAN
Workshop Leader: Silke Jorgens, Senior Statistical Consultant, ICON plc
8.30am - 12.30pm
Speakers
- Alex Sverdlov, Associate Director of Biostatistics at EMD Serono, EMD Serono, Inc
- Bo Huang, director of biostatistics, Pfizer Global Pharmaceuticals
- Bruce Turnbull, Professor of Statistics, Cornell University
- Christopher Jennison, Professor of Statistics and Dean of the Faculty of Science, University of Sheffield
- Filippo Baldacci, Medical Doctor, Neurologist, University of Pisa
- Frank Fleischer, Teamleader Clinical Biostatistics, Boehringer-Ingelheim
- Fredrik Ohrn, Statistical Science Director, AstraZeneca
- Giacomo Mordenti, Senior Director, Grunenthal Gmbh
- Loic Darchy, Senior Statistician, Sanofi Aventis
- Nadia Jessel, Research director, INSERM
- Olivier Collignon, Statistics consultant, European Medicines Agency (EMA)
- Peter Kimani, Assistant Professor in Medical Statistics, Warwick Medical School
- Philip Hougaard, Senior Specialist, Biostatistics, H. Lundbeck A/S
- Pierre Colin, Statistical sciences and modelling, Sanofi Pharma
- Richard Wyse, Director of Research and Development, The Cure Parkinsons Trust
- Robert Clay, Consultant Highbury Regulatory Science Chief Regulatory Officer Kinapse Board Director TOPRA, Highbury Regulatory Science?
- Sidath Katugampola, Biomarker Development Specialist, Cancer Research UK
- Sophie Carr, Bayesian Analyst, Bays Consulting
- Steve Coad, Reader in Statistics, Queen Mary, University of London
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
- Clinical trial managers & associates
- Biostatisticians
- Directors of business developement
- Data managers
- Senior statisticians
- Professors of statistics
- Directors of Clinical trials
- Medical doctors
- PhD students
- Clinical scientists
Venue
Holiday Inn Regents ParkCarburton Street
London
W1W 5EE England
